Anti-Viral Therapies Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Anti-Viral Therapies Market was valued at US$ 39,466.0 Million in 2018 and is expected to reach US$ 50,834.7 Million by 2027 growing at a Compounded Annual Growth Rate (CAGR) of 3% during the forecast period 2021-2027.

Antiviral therapy is one of the most exciting fields of virology. This entails several strategies used to develop antiviral therapies, including direct-acting antiviral agents that target viral proteins, enzymes, or nucleic acids. passive antibodies that neutralize circulating viruses in the drug; and drugs that target cellular proteins or processes essential for viral replication. The global antiviral therapeutics market is driven by factors such as increasing R&D spending by pharmaceutical companies, increasing government support for research activities and clinical trials. However, high drug development costs may hinder market growth. Emerging markets are also creating growth opportunities for market participants.

Market Segments

By Application

• HIV 
• Hepatitis 
• Herpes Virus
• Influenza
• Other Applications

By Type

• Generic Drugs
• Branded Drugs

By Mechanism of Action

• Nucleotide Polymerase Inhibitor
• Reverse Transcriptase Inhibitors
• Protease Inhibitors
• Others

Key Players

• AbbVie Inc.
• Abbott
• F. Hoffmann-La Roche Ltd
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline plc

Scope of the Report

The research study analyzes the global Anti-Viral Therapies industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Anti-Viral Therapies Market Report

1. What was the Anti-Viral Therapies Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Anti-Viral Therapies Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Anti-Viral Therapies Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.